ResMed, Inc. (RMD)
252.39
+0.89
(+0.35%)
USD |
NYSE |
Dec 11, 16:00
252.36
-0.03
(-0.01%)
Pre-Market: 20:00
ResMed Research and Development Expense (Quarterly): 87.32M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| Abbott Laboratories | 748.00M |
| Becton, Dickinson & Co. | 322.00M |
| Insulet Corp. | 77.20M |
| West Pharmaceutical Services, Inc. | 17.10M |